The company is integrating its newly purchased LIMS and genome interpretation and reporting capabilities to provide a single platform for cancer and inherited disease diagnostics.
The Pinnacle assay for gene fusions and gene expression in tumor samples is the first in Cofactor's new line of clinical RNA-sequencing assays.
As PierianDx grows, two customers weighed in on their experiences with the core product, the Clinical Genomicist Workspace, and its NGS-related services.
A new user-friendly software tool is helping Rory Johnson of the University of Bern to do genome-wide screening of lncRNA function by deleting promoters.
The activity follows a recent financing round that has enabled OncoDNA to build out its sales team as it courts new clients.
The cloud-based personalized medicine software company will stay in Cambridge, Massachusetts and will become a wholly-owned subsidiary of the institute.
The software takes somatic mutation profiles from individual patients as input and uses them to prioritize relevant mutations and potential treatments.
EDGE cobbles together several open-source tools into simple pipelines for sequence assembly, taxonomic classification, phylogenetic analysis, and other tasks.
The five-year collaboration will focus on building, optimizing, and sharing tools and resources that will help scientists process and use genomic data.
Over five years, the partners will work on optimizing the GATK and other Broad-developed solutions as well as methods for analyzing distributed datasets.
Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.
An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.
At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.
In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.